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Abstract 1 
In this study, we investigated the anti-proliferative activity and the stability and metabolic fate of 2 
the main dietary hydroxycinnamates, using two colonic adenocarcinoma cell models (Caco-2 and 3 
SW480). Di-hydro-caffeic and di-hydro-ferulic acids were the most effective against cell 4 
proliferation in both cell lines with IC50 values of 71.7 ± 1.1 and 83.1 ± 1.1 μmol/L, respectively 5 
(P<0.05) in Caco-2. At 200 μmol/L, caffeic and ferulic acids inhibited SW480 proliferation by 40.8 6 
± 1.6 and 59.9 ± 1.3%, respectively. Hydroxycinnamic acids with a catechol-type structure were 7 
degraded in Caco-2 cell medium resulting in the production of H2O2. Intracellular Caco-2 UDP-8 
glucuronosyltransferases and catechol-O-methyltransferases were able to form glucuronide and 9 
methyl conjugates. However, only the sulphate conjugates were detected after incubation with 10 
SW480. In addition, simple hydroxycinnamates were released from quinic and aspartic-conjugates. 11 
The remarkable effect of di-hydro-caffeic and di-hydro-ferulic acids against cell proliferation is of 12 
paramount importance since these compounds are the main metabolites detectable at colonic level. 13 
 14 
Keywords: mass spectrometry, metabolism, anti-proliferative activity, phenolic compounds, colon 15 
cancer16 
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1. Introduction 17 
Dietary polyphenols have gained increasing interest because of their numerous biological effects 18 
such as free-radical scavenging and metal chelation activities, modulation of enzymatic activity, 19 
inhibition of cellular proliferation, and altering signal transduction pathways.1-2 In this context, 20 
emerging evidence is confirming the ever-increasing importance of hydroxycinnamic acids in the 21 
prevention of cardiovascular and other chronic diseases.3 Hydroxycinnamic acids are widespread 22 
dietary components found, for instance, in coffee, cherries, apples, chocolate, yerba mate and 23 
several vegetables and herbs.3 The interest in these compounds is related to their beneficial health 24 
effects in vivo.4-5 However, the extent of their protective effect depends on their bioavailability after 25 
intestinal absorption, metabolism, and subsequent interaction with target tissues.1  26 
More interestingly, highly and regularly consumed foods rich in hydroxycinnamic acids are 27 
particularly intriguing for their potential beneficial effects in the gastro-intestinal tract where 28 
hydroxycinnamic acids can reach concentrations of hundreds of μmol/L.3,6,7 To this purpose, recent 29 
epidemiological studies on colorectal cancer risk have demonstrated some evidence of protection 30 
after ingestion of hydroxycinnamates-rich foods or beverages such as coffee and apples.8-10 31 
Furthermore, dark chocolate and cherry intake have been shown to inhibit tumour development in 32 
azoxymethane-induced colonic cancer in rats.11-12  33 
Recently, our research group thoroughly investigated the effect of in vitro gastro-intestinal digestion 34 
on the bioaccessibility of phenolic compounds from two different cherry cultivars (Celeste and 35 
Durone Nero I) and three different types of dark chocolates.13-14 Phenolic acids and especially 36 
hydroxycinnamic acids showed the highest bioaccessibility in all the food matrices. The highest 37 
release after incubation of cherries with digestive fluids was found for coumaroylquinic acids, 38 
followed by feruloylquinic and caffeoylquinic acids; a similar trend was seen for the conjugate 39 
forms of hydroxycinnamic acids with aspartic acid after in vitro digestion of dark chocolate. We 40 
also demonstrated that hydroxycinnamic acids tended to accumulate in cell media suggesting a 41 
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possible role in the anti-proliferative activity of in vitro digested cherry and dark chocolate against 42 
colon adenocarcinoma cell lines.13-14  43 
The stability of phenolic compounds in cell culture media as well as their cellular metabolism are 44 
two aspects to be critically addressed when testing their anti-proliferative activity. Their instability 45 
in cell media may hinder their biological activity, severely changing the concentrations and/or the 46 
chemical structures of the tested compounds.15 Indeed, the cellular metabolism of phenolic 47 
compounds may evidently alter the bioactivity of the tested molecules.16 Therefore, to get a 48 
complete picture of the scenario, the stability of the parent compounds and the formation of their 49 
cellular metabolites should be evaluated. 50 
Thus, the aim of this work was to study the stability and the cell metabolism of cinnamic acid, the 51 
main dietary hydroxycinnamic acids (o-coumaric acid, p-coumaric acid, caffeic acid, ferulic acid 52 
and 5-O-caffeoylquinic acid) as well as the two most important colonic metabolites (di-hydro-53 
caffeic acid and di-hydro ferulic acid) using Caco-2 and SW480 cell lines. Moreover, 54 
coumaroylquinic acids and hydroxycinnamoyl aspartates extracted from sweet cherry (Celeste 55 
cultivar) and dark chocolate, respectively, were also included in the analysis (Figure 1). In addition, 56 
the anti-proliferative effect against two models of human colonic adenocarcinoma cell lines (Caco-2 57 
and SW480) was assessed. The main metabolic pathways were drawn through the detection and 58 
identification of newly-formed metabolites by LC-ESI-IT-MS/MS analysis after 24 h of incubation.  59 
 60 
2. Materials and methods 61 
2.1. Chemicals  62 
Phenolic compound standards (o-coumaric acid, p-coumaric acid, caffeic acid, ferulic acid, di-63 
hydro-caffeic acid, di-hydro ferulic acid, cinnamic acid and 5-O-caffeoylquinic acid) and reagents 64 
for analytical determinations were purchased from Sigma (Milan, Italy). Methanol, formic acid and 65 
acetonitrile were obtained from Carlo Erba (Milan, Italy). All MS/MS reagents were from Bio-Rad 66 
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(Hercules, CA, U.S.A.). All the materials and chemicals for cell culture were from VWR 67 
International (Milan, Italy). MTS cell proliferation assay kit was purchased from Promega (Milan, 68 
Italy). Solid phase extraction (SPE) column (C18, 50 μm, 60 Å, 500 mg) were supplied by Waters 69 
(Milan, Italy).  70 
 71 
2.2. Hydroxycinnamoyl aspartates and coumaroylquinic acids enriched extracts preparation 72 
Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched fractions were extracted from in 73 
vitro digested sweet cherry (Celeste cultivar) and dark chocolate, respectively, following the 74 
protocol reported in Tagliazucchi et al. with some modifications.17 The two food matrices were 75 
digested as reported in Martini et al.14 Firstly, SPE column were preconditioned with 4 mL of 76 
methanol, followed by 5 mL of water adjusted to pH 7.4 with NaOH 1 mol/L. Then, 1 mL of the in 77 
vitro digested fractions were passed through the pre-conditioned C-18 column to adsorb neutral 78 
phenolic compounds. Non-adsorbed phenolic acids were washed with 3 mL of water at pH 7. After 79 
acidification of the column with 5 mL of acidified water (containing 0.1% of formic acid) the 80 
adsorbed phenolic compounds were eluted with 4 mL of an acetonitrile solution (10% acetonitrile 81 
and 90% acidified water). During elution with acetonitrile, four fractions of 1 mL each were 82 
collected separately. These fractions were called ACN1, ACN2, ACN3 and ACN4. The remaining 83 
bound compounds were then eluted with 3 mL of acidified methanol. 84 
Three digested fractions for each food matrix were extracted in triplicate. 85 
Fractions collected from SPE were analyzed by using mass spectrometry to identify phenolic 86 
compounds. Firstly, all of the fractions (2 μL) were directly injected on an ion trap mass 87 
spectrometer coupled with an electrospray ionizator (ESI). ESI operating conditions are reported in 88 
Martini et al.18 The direct infusion experiments were carried out to detect the m/z signals present in 89 
each fraction. Specific fractions containing the m/z signals corresponding to coumaroylquinic acids 90 
(m/z 337) and hydroxycinnamoyl aspartates (m/z 278, 294 and 308 for coumaroyl-aspartate, 91 
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caffeoyl-aspartate and feruloyl-aspartate, respectively) were analyzed by liquid chromatography 92 
electrospray ionization ion trap mass spectrometry (LC-ESI-IT-MS/MS) on HPLC Agilent 1200 93 
Series system equipped with a C18 column (HxSil C18 Reversed phase, 250×4.6 mm, 5 μm particle 94 
size, Hamilton Company, Reno, Nevada, USA). The mobile phase composition was (A) 95 
H2O/formic acid (99:1, v/v) and (B) acetonitrile/formic acid (99:1, v/v). After 0.5 min at 4% B, the 96 
gradient linearly ramped up to 30% B in 60 min. The mobile phase composition was raised up to 97 
100% B in 1 min and maintained for 5 min in order to wash the column before returning to the 98 
initial condition. The flow rate was set at 1 mL/min. The samples were injected in the amount of 40 99 
µL. After passing through the column, the eluate was split and 0.4 mL/min were directed to an 100 
Agilent 6300 ion trap mass spectrometer. Identification of phenolic compounds in all samples was 101 
carried out using full scan and data-dependent MS2 scanning from m/z 100 to 1700. MS operating 102 
conditions, limits of detection (LOD) and limits of quantification (LOQ) for the different standards 103 
are reported in Martini et al.18 Coumaroylquinic acids and coumaroyl-aspartate were quantified as 104 
coumaric acid equivalent whereas caffeoyl-aspartate and feruloyl-aspartate were quantified as 105 
caffeic and ferulic acids equivalents, respectively.  106 
Results were expressed as μmol/L of standard equivalents. 107 
 108 
2.3. Cell cultures and anti-proliferative activity  109 
Human adenocarcinoma Caco-2 cells were cultured in Dulbecco’s Modified Eagle’s Medium 110 
(DMEM) supplemented with 10% fetal bovine serum (FBS), 1% antibiotic mix (streptomycin and 111 
penicillin) and 2 mmol/L L-glutamine. Human adenocarcinoma SW480 cells were cultured in 112 
Leibowitz medium (L-15) supplemented with 10% FBS, 1% antibiotic mix (streptomycin and 113 
penicillin) and 2 mmol/L L-glutamine. Cells were maintained at 37°C in a humidified atmosphere 114 
of 5% CO2.  115 
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Cells were seeded at 4x103/cm2 and 8x103/cm2 for Caco-2 and SW480, respectively, in 96-well 116 
plates for 24 h to allow cell adhesion to the bottom of the wells. 117 
The anti-proliferative activity was assayed by a colorimetric method for the sensitive quantification 118 
of viable cells, using MTS assay kit on Caco-2 and SW480 cell lines as reported in Martini et al.16 119 
Coumaric acids (o- and p-isomers), caffeic, ferulic, di-hydro-caffeic, di-hydro ferulic, 5-O-120 
caffeoylquinic and cinnamic acids standards were dissolved in methanol at concentration of 20 121 
mmol/l and then diluted in both the two cell lines culture media (Caco-2 and SW480) at a final 122 
concentration of 200 μmol/L. A control solution of 1% methanol in cell medium was used as 100% 123 
proliferation. Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched fractions from SPE 124 
were diluted twice in both the two cell lines culture media and the pH was brought to 7.4 with 125 
concentrated NaOH. An appropriate control solution consisting of the elution phase of SPE (10% 126 
acetonitrile and 90% acidified water containing 0.1% of formic acid) diluted twice in the cell 127 
medium and bring to pH 7.4 was used as 100% proliferation. 100 μL of each sample were added to 128 
the cell plates and incubated for 24 h. At the end of the treatment, the media were collected for 129 
detection of newly-formed metabolites and 180 μL of fresh culture medium and 20 μL of MTS 130 
reagent were added to each well. After 4 h of incubation at 37°C, the absorbance was measured at 131 
the wavelength of 490 nm using a microplate reader and results were expressed as percentage of 132 
inhibition of cell proliferation. When possible, the IC50 values, representing concentration of 133 
compound required to inhibit 50% cell proliferation, were determined by incubating cells with 134 
different concentrations of the phenolic compound. IC50 values were expressed as μmol of phenolic 135 
compound/L and were determined using nonlinear regression analysis and fitting the data with the 136 
log (inhibitor) vs. response model generated by GraphPad Prism 6.0 (GraphPad Software, San 137 
Diego, CA, USA). 138 
 139 
2.4. Stability of hydroxycinnamic acids in cell culture media 140 
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Hydroxycinnamic acids were diluted to 200 μmol/L with DMEM or L-15 before testing. 141 
Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched fractions were diluted twice in 142 
both the two cell lines culture media. 100 μL of the diluted hydroxycinnamic acids solution were 143 
incubated at 37 °C in 5% CO2 for 24 h in 96-well plates. At the end of incubation, the samples were 144 
collected from the plates and analyzed by LC-MS/MS analysis as reported in section 2.5. 145 
 146 
2.5. Liquid chromatography coupled to mass spectrometry (LC-MS/MS) analysis of cell media 147 
Cell culture supernatants as well as cell-free media containing hydroxycinnamic acids were 148 
collected after 24 h to test the stability of hydroxycinnamic acids in cell culture media and the 149 
presence of newly-formed metabolites. Cell media were extracted according to Sala et al. and 150 
analyzed using the same LC-ESI-IT-MS/MS system as reported above, with an injection volume of 151 
40 μL and elution flow rate of 1 mL/min.19 The mobile phase composition, the gradient and MS 152 
operating conditions are the same as reported in Martini et al.20 153 
 154 
2.6. Measurement of the concentration of H2O2 in cell media 155 
The generation of H2O2 after 24 h of incubation of hydroxycinnamic acids with cell-free media was 156 
assessed with the FOX assay as reported in Martini et al.20 The concentration of H2O2 was 157 
calculated from a standard curve obtained with different concentrations of H2O2. 158 
 159 
2.7. Statistic 160 
All data are presented as mean ± SD for three replicates for each prepared sample. One-way 161 
analysis of variance (one-way ANOVA) with Tukey’s post-hoc test was applied using Graph Pad 162 
prism 6.0 (GraphPad software, San Diego, CA, U.S.A.). The differences were considered 163 
significant with P<0.05. 164 
 165 
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3. Results  166 
3.1. Anti-proliferative activity of hydroxycinnamic acid standards and colonic metabolites  167 
Treatment for 24 h with p-coumaric, o-coumaric, cinnamic and 5-caffeoylquinic (5-CQA) acids at 168 
200 μmol/L did not affect cell proliferation in both colon adenocarcinoma cell lines (Table 1). 169 
Caffeic and ferulic acids showed some effects, decreasing cell proliferation of SW480 cancer cells 170 
after 24 h treatment at 200 μmol/L. The anti-proliferate activity of ferulic acid against SW480 cell 171 
line was significantly higher than that of caffeic acid (P<0.05) however, neither of the compounds 172 
reduced cell proliferation in Caco-2 cells. The microbial metabolites di-hydro-caffeic (DHC) and 173 
di-hydro-ferulic (DHF) acids were able to notably reduce cell proliferation in both the cell lines. 174 
The effect was significantly higher in Caco-2 respect to SW480 cell line (P<0.05). Contrary to 175 
ferulic acid, the reduced methylated molecule, DHF, was less effective than DHC in SW480 cancer 176 
cells. Indeed, DHC showed higher anti-proliferative activity than caffeic acid. This, however, was 177 
not observed for DHF, which was less efficient than ferulic acid in inhibiting SW480 cell 178 
proliferation. IC50 values for DHC and DHF against Caco-2 cell proliferation were calculated 179 
revealing that DHF was significantly more effective than DHC (71.7 ± 1.1 and 83.1 ± 1.1 μmol/L, 180 
respectively; P<0.05).   181 
 182 
3.2. Stability of hydroxycinnamic acid standards and colonic metabolites in cell-free media 183 
Identification of the standard compounds and metabolites in cell media was based on LC-ESI-184 
MS/MS analyses, and a summary of mass spectrometry data in negative ionization mode is 185 
presented in Table 2. 186 
Results about the stability of individual hydroxycinnamic acids after 24 h incubation with DMEM 187 
(Caco-2 medium) and L-15 (SW480 cell medium) cell-free media are given in Table 3. Some 188 
hydroxycinnamic standards, such as p-coumaric, o-coumaric, ferulic and cinnamic acids, were very 189 
stable even after 24 h incubation in both the cell media. Whereas, caffeic acid was stable during 190 
10 
 
incubation with L-15 but significantly degraded in DMEM after 24 h of incubation (P<0.05). 191 
However, the other tested compounds such as DHC, DHF and 5-CQA were significantly degraded 192 
during incubation with both cell-free media (P<0.05). A new peak with m/z value of 300 appeared 193 
after incubation of DHC in L-15 but not in DMEM (Figure S1). The fragmentation pattern 194 
observed in the LC-MS/MS experiments (fragment ions at m/z 213, 181, 135 and 107) was coherent 195 
with the formation of a DHC-cysteine adduct.21 The concentration of the DHC-cysteine adduct 196 
(quantified as DHC equivalent) accounted for the 40.9% of the initial DHC dose, explaining the 197 
loss of DHC in L-15. 198 
Regarding 5-CQA, after 24 h of incubation in both cell media, two new peaks at m/z 353 were 199 
observed (Figure S2). These new formed compounds showed the typical fragmentation pattern of 200 
3-caffeoylquinic acid (MS2 fragment ions at m/z 191 and 179) and 4-caffeoylquinic acid (MS2 201 
fragment ions at m/z 179, 173, 135 and 191) suggesting that this compound underwent 202 
isomerization during 24 h incubation.18 The sum of the percentage recovery of the three different 203 
isomers of caffeoyl-quinic acid accounted for the 100% of the original standards in L-15 whereas in 204 
DMEM the total recovery was 85.9% (Figure 2A and B).  205 
The production of H2O2 was measured after 24 h of incubation of hydroxycinnamic acids with cell-206 
free media at concentration of 200 μmol /L. In DMEM caffeic acid, DHC and 5-CQA degradation 207 
was accompanied to the generation of H2O2. The highest amounts of H2O2 were found in caffeic 208 
acid and DHC (199.1 ± 17.4 and 241.3 ± 12.2 μmol/L, respectively) followed by 5-CQA (155.3 ± 209 
6.3 μmol/L). No evidence of H2O2 production was observed in the other hydroxycinnamic acids 210 
incubated with DMEM. Indeed, no compounds led to the production of H2O2 during incubation in 211 
L-15. The H2O2 production was also tested after 24 h incubation of DHC in DMEM at 100 μmol/L 212 
(corresponding to about the IC50 value against Caco-2 as reported above), resulting in a H2O2 213 
concentration of 173.7 ± 16.0 μmol/L. 214 
 215 
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3.3. Metabolism of hydroxycinnamic acid standards and colonic metabolites in human 216 
adenocarcinoma colon cell lines 217 
All the tested compounds underwent considerable biotransformations in Caco-2 and SW480 cancer 218 
cells and several newly-formed metabolites were identified (Table 4). In Caco-2, o-coumaric acid 219 
was extensively glucuronidated with the appearance of two isomers of coumaric acid-glucuronide 220 
showing a [M –H]− deprotonated ion at m/z 339, fragmenting to m/z 163 (loss of glucuronide 221 
moiety) and with the characteristic fragmentation pattern of coumaric (m/z 119) and glucuronic 222 
acids (m/z 175 and 113) (Table 2 and Figure S3). The glucuronide-derivative of p-coumaric acid 223 
was instead found only at trace levels (Table 4). Two additional metabolites were found in Caco-2 224 
after incubation with p-coumaric acid: cinnamic acid (identified by comparison with its 225 
corresponding standard) and di-hydro-coumaric acid (m/z 165, fragmenting to m/z 121 226 
corresponding to the loss of CO2). Metabolism by Caco-2 of ferulic acid resulted mainly in the 227 
formation of ferulic acid-glucuronide (m/z 369, fragmenting to m/z 193, corresponding to the loss of 228 
the glucuronide moiety, 175 and 113). Lower amounts of ferulic acid-sulphate (m/z 273, 229 
fragmenting to m/z 193 corresponding to the loss of sulphate group) and DHF (identified by 230 
comparison with its corresponding standard) were also found (Table 4). The most important 231 
metabolites found after incubation of caffeic acid and 5-CQA were (iso)ferulic acid (identified by 232 
comparison with its corresponding standard) and 5-feruloylquinic acid (m/z 367, fragmenting to m/z 233 
179 and 135) while DHF was found only in trace amounts after incubation of DHC with Caco-2 234 
cells (Table 4). Evidence of oxidation of the microbial metabolites DHC and DHF in caffeic and 235 
ferulic acids (identified by comparison with standard compounds) was observed after incubation 236 
with Caco-2 cells. Small amounts of DHF-sulphate (m/z 275, fragmenting to m/z 195 corresponding 237 
to the loss of sulphate group) and DHF-glucuronide (m/z 371, fragmenting to m/z 195, 238 
corresponding to the loss of the glucuronide moiety, and 113) were found after incubation of DHF 239 
with Caco-2. 5-CQA underwent isomerization in 4- and 3-caffeoylquinic acids as observed also 240 
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after incubation with cell-free medium (Table 4 and Figure 2A). The appearance of caffeic acid in 241 
the cell medium after incubation of 5-CQA with Caco-2 was indicative of the presence of esterase 242 
activity. Hydroxylation of cinnamic acid to coumaric acid (identified by comparison with standard 243 
compounds) was the only metabolic pathway observed after incubation of cinnamic acid with Caco-244 
2.  245 
A slightly different metabolic profile was observed with SW480 since the major metabolites found 246 
after incubation with o-coumaric, caffeic and ferulic acids as well as DHC and DHF were the 247 
sulphate conjugates (Table 4). Caffeic acid-sulphate and DHC-sulphate were identified from the 248 
respective parent ions at m/z 259 and 261 producing daughter ions at m/z 179 and 181 (loss of 249 
sulphate group), the un-conjugated forms, by MS2 analysis. Coumaric acid-sulphate (m/z 243) 250 
yielded MS2 fragment ions at m/z 163 and 119, corresponding to the loss of the sulphate moiety 251 
generating coumaric acid and CO2 from the unconjugated molecule, respectively. Trace amounts of 252 
coumaric acid were observed after incubation of caffeic acid with SW480. Instead, no sulphate 253 
conjugates were found for p-coumaric acid, which was extensively reduced to di-hydro-coumaric 254 
acid. The latter was also detected after incubation of o-coumaric acid with SW480 but only in trace 255 
levels. As observed after incubation with cell-free medium, 5-CQA underwent isomerization with 256 
the formation of the 3- and 4-acyl isomers (Table 4 and Figure 2B). Evidence of SW480 esterase 257 
activity should be confirmed by the appearance of free hydroxycinnamic acids after incubation with 258 
5-CQA. Moreover, cinnamic acid was particularly stable with only trace amounts of coumaric acid 259 
detected in the supernatant after incubation with SW480, highlighting the hydroxylating ability of 260 
these cells.  261 
 262 
3.4. Preparation of coumaroylquinic acids and hydroxycinnamoyl aspartates enriched fractions 263 
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The application of the solid phase extraction method on in vitro digested Celeste cherry cultivar and 264 
dark chocolate allowed us to obtain fractions enriched in coumaroylquinic acids and 265 
hydroxycinnamoyl aspartates, respectively.  266 
Figure 3A shows the extracted ion chromatograms at m/z 337 (corresponding to the deprotonated 267 
coumaroylquinic acid molecules) after direct infusion in the mass spectrometer of the different 268 
fractions obtained from the extraction procedure with in vitro digested Celeste cherry cultivar. As 269 
shown, cherry ACN2 was the most enriched fraction in coumaroylquinic acids. The total ion 270 
chromatogram of this fraction determined by direct infusion mass spectrometry revealed the 271 
presence of a prominent signal at m/z 337 and others minor signals at m/z 353 and 413 (Figure 3B). 272 
The LC-MS/MS experiments carried out on fraction ACN2 revealed the presence of seven resolved 273 
peaks (Figure 3C). Table 5 lists the compounds identified in the different observed peaks. The 274 
identification was based on previously reported paper.18 The amount of recovered 4-275 
coumaroylquinic and 5-coumaroylquinic acids (sum of the two isomers) were 72.3 ± 0.9 and 27.7 ± 276 
0.2 μmol/L, respectively. 277 
The direct infusion mass spectrometry of the different fractions obtained with solid phase extraction 278 
from in vitro digested dark chocolate revealed the presence of the typical m/z values of 279 
hydroxycinnamoyl aspartates (m/z 278, 294 and 308 for coumaroyl-aspartate, caffeoyl-aspartate and 280 
feruloyl-aspartate, respectively) in both the chocolate ACN1 and ACN2 fractions (data not shown). 281 
These fractions were further analyzed by liquid chromatography mass spectrometry (LC-MS/MS). 282 
The extracted ion chromatograms of the m/z values corresponding to the hydroxycinnamoyl 283 
aspartates (Figure 4A-C) showed that fraction ACN2 contained higher amount of these compounds 284 
respect to fraction ACN1. The LC-MS/MS experiments carried out on fraction ACN2 revealed the 285 
presence of several peaks as detailed in the base peak chromatogram showed in Figure 4D. 286 
Compounds identified in the observed peaks are reported in Table 5. The identification was based 287 
on previously reported paper.22 The amount of recovered coumaroyl-aspartate, caffeoyl-aspartate 288 
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and feruloyl-aspartate (sum of the two isomers) were 448.2 ± 73.5, 110.3 ± 16.6 and 66.1 ± 9.9 289 
μmol/L, respectively. 290 
 291 
3.5. Anti-proliferative activity, stability in cell-free media and cell metabolism of coumaroylquinic 292 
acids and hydroxycinnamoyl aspartates enriched fractions 293 
Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched fractions were tested for their 294 
anti-proliferative activity after two-fold dilution in cell media. Both the fractions showed notably 295 
anti-proliferative activity against SW480 cells whereas only the hydroxycinnamoyl aspartates 296 
enriched fraction was able to slightly inhibit Caco-2 cell proliferation (Table 1). Table 3 shows 297 
data about the stability of coumaroylquinic acids and hydroxycinnamoyl aspartates after 24 h 298 
incubation with DMEM (Caco-2 medium) and L-15 (SW480 cell medium) cell-free media. Results 299 
showed that coumaroylquinic acids were subject to isomerization in both the cell media (Figure 2C 300 
and D). After 24 h incubation in DMEM, the amount of 4-coumaroylquinic acid decreased by about 301 
43%, whereas the amount of 5-coumaroylquinic acid increased slightly but significantly (P<0.05). 302 
A new signal at m/z 337 was recorded after incubation in DMEM with MS2 product ions at 163, 119 303 
and 191 characteristic of the 3-acyl isomer of coumaroylquinic acid.18 The sum of the percentage 304 
recovery of the three different isomers accounted for about 83% of the original amount. In L-15, the 305 
amount of both the 4- and 5-acyl isomers decreased with the concurrent formation of the 3-acyl 306 
isomer. Incubation of coumaroylquinic acids enriched fraction with Caco-2 resulted in the 307 
formation of some metabolites (Table 4). Hydrolysis of the quinic acid-derivatives by cell esterases 308 
led to the formation of the free coumaric acid. Both coumaroylquinic and coumaric acids were also 309 
detected in the glucuronidated forms. Coumaroylquinic acid-glucuronide showed a precursor ion at 310 
m/z 513 and fragmented at m/z 337 (loss of the glucuronide moiety). The appearance of di-hydro-311 
coumaric acid may be a consequence of the reduction of coumaric acid released from the quinic 312 
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acid-derivative. Isomerization to 3-coumaroyl-quinic acid was also observed as reported after 313 
incubation with cell-free medium (Table 3 and Figure 2C).  314 
The total recovery considering the three isomers was 92.4%. Coumaroyl-aspartate was quite stable 315 
during incubation with both the cell-free media whereas the feruloyl- and caffeoyl-derivatives were 316 
partially degraded (Figure 2E and F). The only metabolites found after incubation of 317 
hydroxycinnamoyl aspartates enriched fraction with Caco-2 cells were the corresponding free 318 
hydroxycinnamic acids. However, feruloyl-aspartate was detected in higher amounts after 319 
incubation with Caco-2 respect to the incubation in cell-free medium suggesting the possible 320 
methylation of the caffeoyl derivative (Table 4 and Figure 2E). Finally, the only metabolite 321 
detected after incubation of the coumaroyl-quinic acid and hydroxycinnamoyl aspartates enriched 322 
fractions with SW480 cells were coumaric and caffeic acids, respectively.  323 
 324 
4. Discussion 325 
Degradation of phenolic compounds during incubation in cell media and their putative cellular 326 
metabolism may represent a limitation in their biological activity such as the anti-proliferative 327 
activity. 328 
In this study, we found that the stability of hydroxycinnamic acids in Caco-2 cell medium (DMEM; 329 
pH 7.4) was strongly correlated with structural motifs of the molecules. The presence of a catechol-330 
type structure in the aromatic ring weakened the stability of hydroxycinnamic acids in DMEM. For 331 
example, caffeic acid bearing a catechol-type structure was clearly less stable than the mono-332 
hydroxylate coumaric acid or ferulic acid where one of the two hydroxyl groups is methylated. 333 
Similarly, DHC was less stable than DHF in Caco-2 cell medium. Hydrogenation of the C7═C8 334 
double bond of hydroxycinnamic acids to corresponding di-hydro-hydroxycinnamic acids also 335 
decreased the stability of the compounds. Phenolic compounds with a catechol-type structure are 336 
easily oxidized at alkaline or slightly alkaline pH values in presence of O2 via the semiquinone 337 
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intermediate formation.15,23  The oxidative degradation of these compounds generate O2•− which 338 
enhance the rate of autoxidation resulting in the formation of H2O2.23 In agreement, we found that 339 
the decrease of caffeic acid and DHC in DMEM resulted in the production of H2O2 suggesting that 340 
the oxidative degradation pathway was the main one of these compounds in DMEM. The stability 341 
of 5-CQA in DMEM was similar to that of caffeic acid; however, the degradation pathways were 342 
slightly different. In addition to the oxidative degradation, the positional isomers 3-CQA and 4-343 
CQA were also produced during incubation. This finding agrees with the results obtained in 344 
previous studies.13,24 345 
The stability profile of the hydroxycinnamic acids in the SW480 cell medium (L-15; pH 7.4) was 346 
quite different respect to those observed after incubation in DMEM. In fact, caffeic acid was stable 347 
during incubation in L-15 suggesting that the oxidative degradation did not occur. Indeed, no H2O2 348 
production was detected in L-15. Surprisingly, DHC was partially degraded after 24 h of incubation 349 
in L-15 medium. However, this was not a consequence of the oxidative degradation pathway (no 350 
formation of H2O2 was observed) but was related to the formation of a DHC-cysteine adduct. This 351 
adduct was not formed in DMEM since cysteine was absent from the medium. 352 
DHF was partially degraded in both the media thorough a not yet identified pathway that did not 353 
involve oxidative degradation, as suggested by the absence of H2O2 in the cell media.  354 
Our data provide evidence that Caco-2 and SW480 cells are able to metabolize hydroxycinnamic 355 
acids by means of phase I and phase II enzymes. Figures 5 and 6 summarize the metabolic 356 
reactions detected in Caco-2 and SW480 cell lines, showing pathways for phase I de-esterification 357 
and hydroxylation and phase II glucuronidation, sulphation, and O-methylation of the various 358 
hydroxycinnamic acids substrates used in this study. 359 
In both the cell lines, small amounts of caffeoylquinic and coumaroylquinic acids were hydrolyzed 360 
resulting in the appearance of free hydroxycinnamic acids. Kern and colleagues reported the 361 
presence of both intracellular and extracellular esterases in Caco-2.25 Farrel et al.26 suggested that 362 
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serine hydrolases might be responsible for the cinnamoyl esterase activity of cultured gastric cells 363 
since these carboxylesterases share similar structural homology and mechanism of hydrolysis with 364 
cinnamoyl esterases. This class of enzymes was detected in Caco-2 cells, as well as in the intestinal 365 
mucosa.26-28 Esterases activity was more heightened in Caco-2 cells respect to SW480. Williamson 366 
et al.28 evidenced that Caco-2 esterases were active against 3-O-caffeoylquinic acid but not versus 367 
5-O-caffeoylquinic and feruloylquinic acids. Here we gave evidence, for the first time, of the 368 
activity of cell esterases against coumaroylquinic acids. We also reported for the first time the 369 
ability of SW480 and, especially, Caco-2 cells to release simple acids (such as caffeic, coumaric 370 
and ferulic acids) from hydroxycinnamoyl-aspartates. In this sense, a hydrolysis of 371 
hydroxycinnamoyl-aspartates catalyzed by membrane bound carboxypeptidases may be 372 
hypothesized. 373 
Our data showed that other phase I reactions might be involved in the metabolism of 374 
hydroxycinnamic acids. Hydroxylation by cytochrome P450 of cinnamic acid resulted in the 375 
formation of coumaric acid. Moreover, de-hydroxylation by phase I reductases brought about the 376 
formation of cinnamic and coumaric acids from coumaric and caffeic acids, respectively. 377 
Whereas, phase II metabolism was found to be cell line- and compound-dependent and varied 378 
notably between the two cell lines and the compounds considered. Major pathways in Caco-2 cells 379 
were glucuronidation and methylation whereas in SW480 sulphation was the predominant one. 380 
Caco-2 UDP-glucuronosyltransferase activity was strongly depended on the type of substrate. 381 
Glucuronidation was a major pathway in ferulic acid metabolism whereas caffeic acid was only 382 
slightly glucuronidated. This result suggested that the presence of the catechol group hinder the 383 
action of the UDP-glucuronosyltransferase. This observation was also supported by the fact that o-384 
coumaric acid was a good substrate for UDP-glucuronosyltransferase. The activity of UDP- 385 
glucuronosyltransferase was also dependent on the position of the OH group in the aromatic ring as 386 
evidenced from the missing identification of glucuronidated metabolites of p-coumaric acid. 387 
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Methylation by catechol-O-methyl transferase was the preferential pathway for caffeic acid 388 
metabolism (both when present as free acid and when conjugate with quinic acid or aspartate), 389 
while ferulic and coumaric acids, lacking the catechol structure, could not be methylated by 390 
catechol-O-methyltransferase. Reduction of ferulic acid to DHF as well as oxidation of DHC to 391 
caffeic acid and DHF to ferulic acid were observed, as already reported by Poquet et al.29 392 
Previous studies with Caco-2 found di-hydro-ferulic acid and ferulic acid-sulphate as the main 393 
metabolite originated from ferulic acid whereas the glucuronidated forms were detected only at 394 
trace levels.25,30,31 Farrel et al.31 and Monente et al.30 also detected caffeic acid-sulphate after 395 
incubation of caffeic acid with Caco-2. Differences between our study and previous works could be 396 
related to the hydroxycinnamic acids incubation with differentiated Caco-2. On the other hand, 397 
incubation for 23 h of ferulic and caffeic acids with non-differentiated Caco-2 (as in our study) 398 
resulted in the appearance of the glucuronidated derivatives without any evidence of sulphation.32 399 
Altogether, these results pointed out a different metabolism between differentiated and non-400 
differentiated Caco-2 cells. No previous studies were available in literature concerning the 401 
metabolism of hydroxycinnamic acids with SW480. 402 
The instability of some hydroxycinnamic acids in Caco-2 cell media may partially explain the 403 
observed results regarding the anti-proliferative activity of hydroxycinnamic acids. During 404 
incubation with Caco-2, caffeic acid was drastically degraded by the oxidative pathway hindering 405 
the detection of any biological activities. Furthermore, caffeic acid was definitely more stable in L-406 
15 than DMEM and was able to reduce SW480 cells proliferation. In addition, 5-CQA was partially 407 
degraded in both the cell media and was devoid of any activity. 408 
The correlation between the observed effects and the stability in the cell media is not always 409 
evident. This is the case of DHC, which was particularly unstable in DMEM resulting in the 410 
formation of H2O2. Despite degradation, DHC was able to reduce Caco-2 cell proliferation in a 411 
concentration-dependent manner. This effect could be related to the production of H2O2. However, 412 
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caffeic acid degradation resulted in a H2O2 production similar to that observed when DHC was 413 
incubated at 100 μmol/L (corresponding at about the IC50 value against Caco-2) without anti-414 
proliferative activity. These observations suggest that H2O2 did not have a key role in the anti-415 
proliferative action of DHC. Similarly, DHF was quite unstable in both the media but was able to 416 
exert anti-proliferative effect.  417 
Phase II enzymes in Caco-2 cells extensively metabolized some hydroxycinnamic acids, such as 418 
coumaric, ferulic and coumaroyl-quinic acids. Previous studies demonstrated that phase II 419 
metabolites of phenolic compounds presented reduced biological activities respect to the parent 420 
compounds.33,34 González-Sarrías and co-worker demonstrated that glucuronidation of urolithins 421 
during incubation with HT29 cells limits their anti-proliferative activity.33 Similarly, 422 
glucuronidation of hesperetin by Raw264.7 cells reduced its anti-inflammatory activity.35 In this 423 
study, we found that SW480 cells displayed lower metabolic activity and the majority of the 424 
hydroxycinnamic acids showed appreciable anti-proliferative activity. Ferulic acid was clearly 425 
stable in both the cell media but active only against SW480 proliferation. During incubation with 426 
Caco-2 ferulic acid was extensively glucuronidated and, to a lesser extent, sulphated. The Caco-2 427 
metabolism of ferulic acid may have hampered their anti-proliferative activity against this cell line. 428 
Some of the tested standard compounds and metabolites were recovered in significantly lower 429 
amount after incubation with cells (Table 4) respect to the amount observed after incubation with 430 
cell-free media (Table 3) such as p-coumaric acid, caffeic acid and DHF in Caco-2 and caffeic acid, 431 
o-coumaric acid, ferulic acid and 5-CQA in SW480. These compounds could be metabolized in un-432 
identified compounds or transported inside the cells. Some studies suggest that hydroxycinnamic 433 
acids can be transported in Caco-2 cells. For example, Konishi and co-worker reported that p-434 
coumaric and caffeic acids but not 5-CQA were efficiently transported across Caco-2 membrane 435 
via the monocarboxylic acid transporter (MCT).36 Moreover, Monente et al. found that the 436 
transepithelial transport of DHF in Caco-2 cells was more pronounced than that of DHC.30 No 437 
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studies about the possible transport of phenolic compounds across SW480 are present in literature. 438 
However, these colon cancer cells express high level of MCT.37    439 
It is useful mentioning that the observed different susceptibility of the two studied cancer cell lines 440 
could reflect their different gene expressions, differentiation stages, proliferative rates, nevertheless 441 
their distinct capacity to metabolize and accumulate hydroxycinnamic acids.   442 
Despite their stability in the upper gastro-intestinal tract, hydroxycinnamic acids are thoroughly 443 
modified in the colon by the action of colonic microbiota. Ludwig and colleagues identified a total 444 
of 11 metabolites after in vitro colonic fermentation by human microbiota of coffee caffeoylquinic 445 
and feruloylquinic acids.38 However, basing on quantitative data, they observed that major 446 
degradation pathways led to the accumulation of DHC and DHF.38 Further in vivo studies have 447 
confirmed free and sulphated DHC and DHF as main metabolites in plasma and urine after 448 
ingestion of coffee.39,40 DHC and DHF have also been identified after in vitro colonic fermentation 449 
of blueberries, oat and wheat bran, orange and apple juices as well as black and green tea.41 450 
Therefore, it is important to investigate the potential anti-proliferative effect of hydroxycinnamic 451 
acid colonic metabolites in colon adenocarcinoma cell systems.42 The results with the reduced 452 
microbial metabolites, DHC and DHF, showed that they were more effective than the parent 453 
compounds in inhibiting Caco-2 proliferation. DHC was also more active than caffeic acid against 454 
SW480 whereas ferulic acid was more effective than DHF in inhibiting SW480 proliferation.  455 
In addition to standard hydroxycinnamic acids and colonic metabolites, we also tested two different 456 
extracts obtained from in vitro digested cherry and dark chocolate with the aim to increase our 457 
previous findings and identify the possible compounds involved in the already reported anti-458 
proliferative activity.13,14 The two extracts were enriched in coumaroylquinic acids (from digested 459 
cherry) and hydroxycinnamoyl aspartates (from digested dark chocolate). Similarly to what was 460 
observed for in vitro digested cherry, the coumaroylquinic acids enriched extract was effective 461 
against SW480 but not on Caco-2 cell proliferation. These results pointed out that this fraction 462 
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contained the causative compounds of the anti-proliferative activity of in vitro digested cherry.13 463 
This extract was enriched in coumaroylquinic acids but also contained other compounds such as 3- 464 
and 4-caffeoylquinic acids and roseoside. In this study, we demonstrated that caffeoylquinic acids 465 
were not effective against SW480 cells proliferation. Concerning roseoside, no studies about its 466 
effect on colon cancer Caco-2 and SW480 cells were found in literature. Differently, the 467 
hydroxycinnamoyl aspartates extract was able to inhibit the proliferation of both the colon cancer 468 
cell lines but was three-times more effective against SW480. These results fitted with the data 469 
obtained with in vitro digested dark chocolate and suggested that this fraction contained the active 470 
compounds.14 Besides hydroxycinnamoyl aspartates, the extract also contained (epi)catechin 471 
sulphate and 12-hydroxy jasmonic acid sulphate. Ramos et al. reported that 24 h treatment of Caco-472 
2 and SW480 with catechin, epicatechin or procyanidin B2 did not affect cell growth.43 No studies 473 
about the effect of 12-hydroxy jasmonic acid sulphate on colon cancer Caco-2 and SW480 cells or 474 
against others cancer cell lines were found in literature. However, methyl jasmonic acid was found 475 
to be able to inhibit in vitro cancer cell proliferation and to induce cell death in several cancer cell 476 
lines, including colon cancer HT29.44 477 
These results indicated that some hydroxycinnamic acids at a concentration close to those which 478 
they can achieve in the gastro-intestinal tract after the consumption of hydroxycinnamic acid-rich 479 
foods and beverages, may exert anti-proliferative activity. In particular, the remarkable effect of di-480 
hydro-caffeic and di-hydro-ferulic acids against cell proliferation is of paramount importance since 481 
these compounds are the main metabolites detectable at colonic level after the consumption of 482 
hydroxycinnamates-rich foods. This study suggests that these metabolites could be the real active 483 
molecules involved in the reported biological effects of hydroxycinnamic acid-rich foods, especially 484 
those effects related to gastrointestinal pathologies such as colon cancer. 485 
Our results highlighted that the drastic biotransformations of hydroxycinnamic acids occurring in 486 
cell cultures should be carefully taken into account in order to fully understand the real compounds 487 
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exerting the observed bioactivities. Some compounds were drastically degraded in culture medium 488 
whereas some other compounds were extensively metabolized in phase II metabolites, which could 489 
have resulted in a reduction of their anti-proliferative activity. This integrated approach may 490 
therefore be relevant to understand the molecules and mechanisms responsible for the biological 491 
effects of phenolic metabolites. 492 
Finally, hydroxycinnamic acids and especially their colonic metabolites di-hydro-caffeic and di-493 
hydro-ferulic acids might have interesting anti-proliferative potential in colon cancer prevention, 494 
warranting further studies to confirm this relationship as well as the possible mechanisms of action.495 
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Figure captions 
Figure 1. Structure of hydroxycinnamic acids used in this study. R1=OH, R2=H: o-coumaric 
acid. R1=H, R2=OH: p-coumaric acid. 
Figure 2. Recovery and isomerization of hydroxycinnamoyl-quinic acids and 
hydroxycinnamoyl aspartates. (A, C, E) Caco-2; (B, D, F) SW480. Black columns represent the 
percentage of the different isomers at the beginning of incubation (time 0). Light grey columns 
represent the percentage of the different isomers after 24 h of incubation in cell-free media. Dark 
grey columns represent the percentage of the different isomers after 24 h of incubation with cells. 
CQA: caffeoylquinic acid; CoQA: coumaroylquinic acid. Values in the same graph with different 
lowercase letter are significantly different (P<0.05). Coumaroylquinic acids enriched fraction was 
obtained from in vitro digested cherry as reported in materials and methods section. 
Hydroxycinnamoyl aspartates enriched fraction was obtained from in vitro digested dark chocolate 
as reported in materials and methods section.  
Figure 3. Preparation of coumaroylquinic acids enriched fraction from in vitro digested 
cherry. (A) Extracted ion chromatogram at m/z 337 from direct infusion of ACN fractions obtained 
from solid phase extraction of in vitro digested Celeste cherry cultivar. Dashed line represents 
ACN1 fraction. Solid line represents ACN2 fraction. Dotted line represents ACN3 fraction. Light 
grey solid line represents ACN4 fraction. Grey solid line represents methanolic fraction. (B) Total 
ion chromatogram obtained from direct infusion of fraction ACN2. (C) Base peak chromatogram of 
fraction ACN2. 
Figure 4. Preparation of hydroxycinnamoyl aspartates enriched fraction from in vitro 
digested dark chocolate. Extracted ion chromatograms at m/z 278 (A), 294 (B) and 308 (C) from 
fraction ACN1 (solid black line) and ACN2 (solid grey line). (D) Base peak chromatogram of 
fraction ACN2. 
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Figure 5. Proposed pathways for hydroxycinnamic acids metabolism after incubation with 
Caco-2 cell line. COMT: catechol-O-methyl transferase; CPase: carboxypeptidase; EST: esterase; 
RA: reduction; OX: oxidation; DHY: de-hydroxylation; HYD: hydroxylation; SULT: 
sulfotransferase; UDP-GT: UDP-glucuronosyltransferase. Bold arrows indicate major routes. 
Percentages indicate the extent of biotransformation. 
Figure 6. Proposed pathways for hydroxycinnamic acids metabolism after incubation with 
SW480 cell line. CPase: carboxypeptidase; EST: esterase; OX: oxidation; DHY: de-hydroxylation; 
HYD: hydroxylation; SULT: sulfotransferase. Bold arrows indicate major routes. Percentages 
indicate the extent of biotransformation.
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Table 1. Effect of hydroxycinnamic acids and coumaroyl-quinic acids and hydroxycinnamoyl-
aspartates-enriched fractions on the proliferation of colon adenocarcinoma human cell lines. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hydroxycinnamic acids were tested at 200 μmol/L. Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched 
fractions were tested after two-fold dilution in cell media. Coumaroylquinic acids final concentration in the cell media 
were 36.2 and 13.9 μmol/L for 4-coumaroyl-quinic and 5-coumaroyl-quinic acids, respectively. Hydroxycinnamoyl-
aspartates concentration in the cell media were 224, 55.2 and 33.1 μmol/L for coumaroyl-aspartate, caffeoyl-aspartate 
and feruloyl-aspartate, respectively. 
n.a. means no activity 
Values with different uppercase letters are significantly different (P<0.05). 
 
Compound 
Caco-2  SW 480 
% inhibition  % inhibition 
Standards 
 
 
 
Cinnamic acid n.a.  n.a. 
p-Coumaric acid n.a.  n.a. 
    
o-Coumaric acid n.a.  7.23 ± 3.86e 
    Caffeic acid n.a.  40.8 ± 1.63c 
    Ferulic acid n.a.  59.9 ± 1.29e 
    5-Caffeoylquinic acid n.a.  n.a. 
    Di-hydro-caffeic acid 101 ± 1.70a  46.8 ± 1.05b 
    Di-hydro-ferulic acid 100 ± 2.11a  37.3 ± 1.21cd 
    Extracts 
 
 
 
Coumaroylquinic acids-
enriched fraction n.a. 
 
41.4 ± 3.31bc 
    Hydroxycinnamoyl 
aspartates enriched fraction 10.7 ± 1.92e 
 
34.2 ± 1.55d 
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Table 2. Mass spectral characteristics of hydroxycinnamic acid standards and their metabolites 
identified in this study 
 
Compound [M-H]
-
 
(m/z) MS
2
 ion fragments (m/z) 
Caffeic acid* 179                                                           135 (100%) 
Caffeic acid-glucuronide 355                                                           179 (100%) 
Caffeic acid-sulphate 259                                        179 (100%), 135 (19%) 
3-O-Caffeoylquinic acid 353 191 (100%), 179 (43%), 135 (9%) 
4-O-Caffeoylquinic acid 353 179 (100%), 173 (44%), 135 (40%), 191 (27%) 
5-O-Caffeoylquinic acid* 353                                          191 (100%), 173 (3%) 
Cinnamic acid * 147 103 (100%) 
o-Coumaric acid* 163 119 (100%) 
p-Coumaric acid* 163 119 (100%) 
Coumaric acid-glucuronide 339 113 (100%), 163 (35%), 119 (21%), 175 (7%) 
Coumaric acid-sulphate 243 163 (100%), 119 (14%) 
Di-hydro-caffeic acid* 181 137 (100%) 
Di-hydro-caffeic acid-cysteine 300 213 (100%), 135 (76%), 181 (65%), 107 (40%) 
Di-hydro-caffeic acid-sulphate 261 181 (100%) 
Di-hydro-coumaric acid 165 121 (100%) 
Di-hydro-ferulic acid* 195 177 (100%), 136 (99%), 151 (11%), 175 (7%) 
Di-hydro-ferulic acid-glucuronide 371 195 (100%), 113 (65%) 
Di-hydro-ferulic acid-sulphate 275 195 (100%) 
Ferulic acid* 193 178 (100%), 134 (94%), 149 (79%) 
Ferulic acid-glucuronide 369 175 (100%), 193 (42%), 113 (40%) 
Ferulic acid-sulphate 273 193 (100%) 
5-O-Feruloylquinic acid 367 179 (100%), 135 (30%) 
*Identified by comparison with the corresponding standard 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
34 
 
Table 3. Stability of hydroxycinnamic acids and coumaroylquinic acids and hydroxycinnamoyl 
aspartates enriched fractions after 24 h of incubation in Caco-2 and SW480 cell media without cells. 
Results are expressed as % recovery respect to the initial dose. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hydroxycinnamic acids were tested at 200 μmol/L. Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched 
fractions were tested after two-fold dilution in cell media. Coumaroylquinic acids final concentration in the cell media 
were 36.2 and 13.9 μmol/L for 4-coumaroyl-quinic and 5-coumaroyl-quinic acids, respectively. Hydroxycinnamoyl-
aspartates concentration in the cell media were 224, 55.2 and 33.1 μmol/L for coumaroyl-aspartate, caffeoyl-aspartate 
and feruloyl-aspartate, respectively. 
*means significantly different from the initial amount 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Compounds 
Caco-2 medium SW 480 medium 
% recovery % recovery 
   Standards 
  
Cinnamic acid 100 ± 1.57 100 ± 1.01 
p-Coumaric 100 ± 0.07 84.7 ± 1.44* 
o-Coumaric 96.1 ± 0.51 96.4 ± 0.94 
Caffeic acid 56.3 ± 1.34* 97.2 ± 1.44 
Ferulic acid 93.1 ± 2.27 100 ± 0.58 
5-Caffeoylquinic acid 35.3 ± 0.33* 63.2 ± 2.36* 
Di-hydro-caffeic acid 35.3 ± 0.52* 70.8 ± 0.42* 
Di-hydro-ferulic acid 71.1 ± 0.33* 69.7 ± 1.34* 
   Coumaroylquinic acids  enriched 
fractions   
4-Coumaroylquinic acid 56.8 ± 1.32* 64.6 ± 0.34* 
5-Coumaroylquinic acid 124.2 ± 2.06* 47.3 ± 0.92* 
   Hydroxycinnamoyl aspartates enriched 
fractions   
Coumaroyl-aspartate 90.4 ± 4.31 94.6 ± 0.88 
Caffeoyl-aspartate 57.2 ± 0.74* 47.6 ± 0.41* 
Feruloyl-aspartate 62.3 ± 0.39* 88.4 ± 1.27* 
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Table 4. Recovery (% of initial dose) of free hydroxycinnamic acids and their metabolites in 
the Caco-2 and SW480 extracellular culture medium after 24 h of incubation with cells. 
Compounds Caco-2 % of initial dose 
SW 480 
% of initial dose 
   Substrate 
 
 
Cinnamic acid 101 ± 1.46 100 ± 1.01 
Metabolites 
 
 
Coumaric acid Traces Traces 
Total 101 ± 1.46 100 ± 1.01 
   Substrate 
 
 
p-Coumaric acid  76.3 ± 0.73 72.9 ± 2.70 
Metabolites 
 
 
p-Coumaric acid glucuronide  Traces n.d. 
Cinnamic acid  Traces n.d. 
Di-hydro-coumaric acid Traces 13.8 ± 0.40 
Total 76.3 ± 0.73* 86.7 ± 2.73 
   Substrate 
 
 
o-Coumaric acid  63.3 ± 0.31 55.2 ± 1.05 
Metabolites 
 
 
o-Coumaric acid glucuronide isomer 1 0.55 ± 0.02 n.d. 
o-Coumaric acid glucuronide isomer 2 43.6 ± 1.11 n.d. 
Di-hydro-coumaric acid n.d. Traces 
Coumaric acid sulphate n.d. 32.0 ± 0.95 
Total 107 ± 1.15 87.2 ± 1.42* 
   Substrate 
 
 
Caffeic acid 46.4 ± 0.40 57.7 ± 2.62 
Metabolites 
 
 
Ferulic acid 3.08 ± 0.07 n.d. 
Coumaric acid Traces Traces 
Caffeic acid glucuronide 0.11 ± 0.01 n.d. 
Caffeic acid sulphate n.d. 0.24 ± 0.02 
Total 49.6 ± 0.41* 57.9 ± 2.62* 
   Substrate 
 
 
Ferulic acid 82.0 ± 0.21 48.2 ± 1.00 
Metabolites 
 
 
Ferulic acid glucuronide 21.9 ± 0.82 n.d. 
Di-hydro-ferulic acid Traces n.d. 
Ferulic acid sulphate 4.01 ± 0.08 2.90 ± 0.24 
Total 107 ± 0.85 51.1 ± 1.03* 
   Substrate   
5-Caffeoylquinic acid 41.2 ± 1.50 45.5 ± 0.41 
Metabolites   
3-Caffeoylquinic acid 14.5 ± 0.21 2.52 ± 0.13 
4-Caffeoylquinic acid 19.7 ± 1.90 43.1 ± 1.02 
Caffeic acid 0.27 ± 0.01 Traces 
5-Feruloylquinic acid 17.0 ± 0.57 n.d. 
Total 92.7 ± 2.50 91.1 ± 1.11* 
   Substrate 
 
 
Di-hydro-caffeic acid 30.7 ± 0.27 76.9 ± 0.95 
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Hydroxycinnamic acids were tested at 200 μmol/L. Coumaroylquinic acids and hydroxycinnamoyl aspartates enriched 
fractions were tested after two-fold dilution in cell media. Coumaroylquinic acids final concentration in the cell media 
were 36.2 and 13.9 μmol/L for 4-coumaroyl-quinic and 5-coumaroyl-quinic acids, respectively. Hydroxycinnamoyl-
aspartates concentration in the cell media were 224, 55.2 and 33.1 μmol/L for coumaroyl-aspartate, caffeoyl-aspartate 
and feruloyl-aspartate, respectively. 
n.d. means not detected 
*means significantly different from the amount recovered after incubation with cell-free media (Table 3). 
Metabolites 
 
 
Di-hydro-ferulic acid Traces n.d. 
Caffeic acid  0.87 ± 0.01 n.d. 
Di-hydro-caffeic acid cysteine n.d. 23.8 ± 1.12 
Di-hydro-caffeic acid sulphate n.d. 4.77 ± 0.12 
Total 31.6 ± 0.27 105 ± 1.47 
   Substrate 
 
 
Di-hydro-ferulic acid 46.9 ± 1.45 63.2 ± 2.17 
Metabolites 
 
 
Di-hydro-ferulic acid glucuronide 0.53 ± 0.01 n.d. 
Ferulic acid  0.22 ± 0.01 n.d. 
Di-hydro-ferulic acid sulphate 0.71 ± 0.01 2.98 ± 0.03 
Total 48.4 ± 1.45* 66.2 ± 2.17 
   Substrate 
 
 
4-Coumaroylquinic acid  25.9 ± 0.19 31.0 ± 0.64 
5-Coumaroylquinic acid  26.6 ± 0.11 20.5 ± 2.08 
Metabolites 
 
 
3-Coumaroylquinic acid  30.4 ± 0.15 23.9 ± 0.24 
Coumaroylquinic acid glucuronide 2.29 ± 0.04 
 
n.d. 
Di-hydro-coumaric acid 3.26 ± 0.09 n.d. 
Coumaric acid glucuronide 6.67 ± 0.12 n.d. 
Coumaric acid 3.47 ± 0.02 Traces 
Total 98.6 ± 0.31 75.4 ± 2.19* 
   Substrate 
 
 
Caffeoyl-aspartate  7.62 ± 0.95 42.6 ± 8.78 
 Coumaroyl-aspartate  27.2 ± 2.87 8.31 ± 0.58 
Feruloyl-aspartate  9.56 ± 1.08 9.54 ± 0.25 
Metabolites 
  
Caffeic acid 1.55 ± 0.21 0.52 ± 0.02 
Ferulic acid 0.42 ± 0.02 n.d. 
Coumaric acid 0.41 ± 0.02 n.d. 
Total 46.8 ± 3.22* 61.0 ± 8.80* 
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Table 5. Mass spectral characteristics of compounds identified in the coumaroyl quinic acids and 
hydroxycinnamoyl aspartates enriched extracts 
 
Peak Compound [M-H]
-
 
(m/z) MS
2
 ion fragments (m/z) 
  
Coumaroylquinic acids enriched fraction 
1 3-Caffeoylquinic acid  353 191 (100%), 179 (43%), 135 (9%) 
2 4-Caffeoylquinic acid 353 179 (100%), 173 (44%), 135 (40%), 191 (27%) 
3 4-Coumaroylquinic acid cis 337 173 (100%), 163 (6%) 
4 Roseoside 431 385 (100%), 153 (11%), 223 (6%) 
5 4-Coumaroylquinic acid trans 337 173 (100%), 163 (4%) 
6 5-Coumaroylquinic acid trans 337 191 (100%), 173 (3%), 163 (2%) 
7 5-Coumaroylquinic acid cis 337 191 (100%), 163 (7%), 173 (2%) 
Hydroxycinnamoyl aspartates enriched fraction 
1 Caffeoyl aspartate isomer 1 249 132 (100%), 179 (79%), 227 (36%), 276 (34%), 
250 (14%)  
2 Caffeoyl aspartate isomer 2 249 132 (100%), 276 (54%), 179 (31%), 232 (2%)  
3 Coumaroyl aspartate isomer 1 278 132 (100%), 163 (48%), 234 (19%), 119 (3%)  
4 Feruloyl aspartate isomer 1 308 193 (100%) 
5 Coumaroyl aspartate isomer 2 278 132 (100%), 163 (74%), 119 (24%), 234 (6%)   
6 Feruloyl aspartate isomer 2 308 193 (100%), 149 (65%), 132 (35%) 
7 (Epi)catechin-O-sulphate 369 289 (100%), 245 (9%), 125 (9%) 
8 12-hydroxy jasmonic acid sulphate 
isomer 1 
305 97 (100%), 225 (35%) 
9 12-hydroxy jasmonic acid sulphate 
isomer 2 
305 97 (100%), 225 (33%) 
 
Coumaroylquinic acids enriched fraction was obtained from in vitro digested cherry as reported in material and methods 
section. Peaks are numbered as reported in Figure 3C. Hydroxycinnamoyl aspartates enriched fraction was obtained 
from in vitro digested dark chocolate as reported in material and methods section. Peaks are numbered as reported in 
Figure 4D. 
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